DOI QR코드

DOI QR Code

Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-κB activation

  • Bak, Sun-Uk (Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University) ;
  • Kim, Suji (Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University) ;
  • Hwang, Hae-Jun (Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University) ;
  • Yun, Jung-A (Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University) ;
  • Kim, Wan-Sung (Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University) ;
  • Won, Moo-Ho (Department of Neurobiology, School of Medicine, Kangwon National University) ;
  • Kim, Ji-Yoon (Department of Anesthesiology and Pain Medicine, Hanyang University Hospital) ;
  • Ha, Kwon-Soo (Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University) ;
  • Kwon, Young-Guen (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) ;
  • Kim, Young-Myeong (Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University)
  • Received : 2016.12.19
  • Accepted : 2017.01.13
  • Published : 2017.02.28

Abstract

Heme oxygenase (HO-1) catalyzes heme to carbon monoxide (CO), biliverdin/bilirubin, and iron and is known to prevent the pathogenesis of several human diseases. We assessed the beneficial effect of heme degradation products on osteoclastogenesis induced by receptor activator of NF-${\kappa}B$ ligand (RANKL). Treatment of RAW264.7 cells with CORM-2 (a CO donor) and bilirubin, but not with iron, decreased RANKL-induced osteoclastogenesis, with CORM-2 having a more potent anti-osteogenic effect. CORM-2 also inhibited RANKL-induced osteoclastogenesis and osteoclastic resorption activity in marrow-derived macrophages. Treatment with hemin, a HO-1 inducer, strongly inhibited RANKL-induced osteoclastogenesis in wild-type macrophages, but was ineffective in $HO-1^{+/-}$ cells. CORM-2 reduced RANKL-induced NFATc1 expression by inhibiting IKK-dependent NF-${\kappa}B$ activation and reactive oxygen species production. These results suggest that CO potently inhibits RANKL-induced osteoclastogenesis by inhibiting redox-sensitive NF-${\kappa}B$-mediated NFATc1 expression. Our findings indicate that HO-1/CO can act as an anti-resorption agent and reduce bone loss by blocking osteoclast differentiation.

Keywords

References

  1. Asagiri M and Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40, 251-264 https://doi.org/10.1016/j.bone.2006.09.023
  2. Boyle WJ, Simonet WS and Lacey DL (2003) Osteoclast differentiation and activation. Nature 423, 337-342 https://doi.org/10.1038/nature01658
  3. Kobayashi N, Kadono Y, Naito A et al (2001) Segregation of TRAF6-mediated signalling pathways clarifies its role in osteoclastogenesis. EMBO J 20, 1271-1280 https://doi.org/10.1093/emboj/20.6.1271
  4. Walsh MC, Kim N, Kadono Y et al (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24, 33-63 https://doi.org/10.1146/annurev.immunol.24.021605.090646
  5. Asagiri M, Sato K, Usami T, Ochi S, Nishina H and Yoshida H (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202, 1261-1269 https://doi.org/10.1084/jem.20051150
  6. Ayer A, Zarjou A, Agarwal A and Stocker R (2016) Heme oxygenases in cardiovascular health and disease. Physiol Rev 96, 1449-1508 https://doi.org/10.1152/physrev.00003.2016
  7. Kim YM, Pae HO, Park JE et al (2011) Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 14, 137-167 https://doi.org/10.1089/ars.2010.3153
  8. Van Phan T, Sul OJ, Ke K et al (2013) Carbon monoxide protects against ovariectomy-induced bone loss by inhibiting osteoclastogenesis. Biochem Pharmacol 85, 1145-1152 https://doi.org/10.1016/j.bcp.2013.01.014
  9. Tseng FJ, Chia WT, Wang CH et al (2015) Carbon monoxide inhibits receptor activator of NF-${\kappa}B$ (RANKL)-induced osteoclastogenesis. Cell Physiol Biochem 36, 1250-1258 https://doi.org/10.1159/000430294
  10. Ke K, Safder MA, Sul OJ et al (2015) Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast. Mol Cell Endocrinol 409, 11-20 https://doi.org/10.1016/j.mce.2015.03.022
  11. Boyce BF (2013) Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res 92, 860-867 https://doi.org/10.1177/0022034513500306
  12. Ryter SW, Alam J and Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86, 583-650 https://doi.org/10.1152/physrev.00011.2005
  13. Lee S, Lee SJ, Coronata AA et al (2014) Carbon monoxide confers protection in sepsis by enhancing beclin 1-dependent autophagy and phagocytosis. Antioxid Redox Signal 20, 432-442 https://doi.org/10.1089/ars.2013.5368
  14. Choi YK, Maki T, Mandeville ET et al (2016) Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury. Nat Med 22, 1335-1341 https://doi.org/10.1038/nm.4188
  15. Takayanagi H, Kim S, Koga T et al (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901 https://doi.org/10.1016/S1534-5807(02)00369-6
  16. Santoro MG, Rossi A and Amici C (2003) NF-${\kappa}B$ and virus infection: who controls whom. EMBO J 22, 2552-2560 https://doi.org/10.1093/emboj/cdg267
  17. Nakahira K, Kim HP, Geng XH et al (2006) Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203, 2377-2389 https://doi.org/10.1084/jem.20060845
  18. Chi PL, Liu CJ, Lee IT, Chen YW, Hsiao LD and Yang CM (2014) HO-1 induction by CO-RM2 attenuates TNF-${\alpha}$-induced cytosolic phospholipase A2 expression via inhibition of $PKC{\alpha}$-dependent NADPH oxidase/ROS and NF-${\kappa}B$. Mediators Inflamm 2014, 279171
  19. Lee NK, Choi YG, Baik JY et al (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852-859 https://doi.org/10.1182/blood-2004-09-3662
  20. Ha H, Kwak HB, Lee SW et al (2004) Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 301, 119-127 https://doi.org/10.1016/j.yexcr.2004.07.035
  21. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN and Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046 https://doi.org/10.1126/science.3029864
  22. Yeh PY, Li CY, Hsieh CW, Yang YC, Yang PM and Wung BS (2014) CO-releasing molecules and increased heme oxygenase-1 induce protein S-glutathionylation to modulate NF-${\kappa}B$ activity in endothelial cells. Free Radic Biol Med 70, 1-13 https://doi.org/10.1016/j.freeradbiomed.2014.01.042
  23. Kang N, Koo J, Wang S, Hur SJ and Bahk YY (2016) A systematic study of nuclear interactome of C-terminal domain small phosphatase-like 2 using inducible expression system and shotgun proteomics. BMB Rep 49, 319-324 https://doi.org/10.5483/BMBRep.2016.49.6.240
  24. Park GS, Kim JK and Kim JH (2016) Anti-inflammatory action of ethanolic extract of Ramulus mori on the BLT2-linked cascade. BMB Rep 49, 232-237 https://doi.org/10.5483/BMBRep.2016.49.4.002

Cited by

  1. Nrf2/HO-1 mediates the neuroprotective effect of mangiferin on early brain injury after subarachnoid hemorrhage by attenuating mitochondria-related apoptosis and neuroinflammation vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-12160-6
  2. Heme oxygenase-1 attenuates the inhibitory effect of bortezomib against the APRIL-NF-κB-CCL3 signaling pathways in multiple myeloma cells: Corelated with bortezomib tolerance in multiple myeloma pp.07302312, 2018, https://doi.org/10.1002/jcb.27879
  3. Uncoupled Endothelial Nitric Oxide Synthase Enhances p-Tau in Chronic Traumatic Encephalopathy Mouse Model pp.1557-7716, 2018, https://doi.org/10.1089/ars.2017.7280
  4. in LPS-Stimulated RAW264.7 Macrophages vol.15, pp.9, 2018, https://doi.org/10.1002/cbdv.201800203
  5. Protective role of heme oxygenase-1 in fatty liver ischemia–reperfusion injury pp.1860-1499, 2018, https://doi.org/10.1007/s00795-018-0205-z
  6. Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway vol.12, pp.3, 2018, https://doi.org/10.5582/bst.2018.01107
  7. Various roles of heme oxygenase-1 in response of bone marrow macrophages to RANKL and in the early stage of osteoclastogenesis vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-29122-1